These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 31902661)

  • 1. Effects of lipophilicity and functional groups of synthetic cannabinoids on their blood concentrations and urinary excretion.
    Kakehashi H; Shima N; Ishikawa A; Nitta A; Asai R; Wada M; Nakano S; Matsuta S; Sasaki K; Kamata H; Kamata T; Nishioka H; Miki A; Katagi M
    Forensic Sci Int; 2020 Feb; 307():110106. PubMed ID: 31902661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of the recently emerged synthetic cannabinoid 5F-MDMB-PICA in 'legal high' products and human urine samples.
    Mogler L; Franz F; Rentsch D; Angerer V; Weinfurtner G; Longworth M; Banister SD; Kassiou M; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Jan; 10(1):196-205. PubMed ID: 28371476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of synthetic cannabinoids in blood samples from Norwegian drivers suspected of impaired driving during a seven weeks period.
    Tuv SS; Krabseth H; Karinen R; Olsen KM; Øiestad EL; Vindenes V
    Accid Anal Prev; 2014 Jan; 62():26-31. PubMed ID: 24129318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA.
    Hermanns-Clausen M; Müller D; Kithinji J; Angerer V; Franz F; Eyer F; Neurath H; Liebetrau G; Auwärter V
    Clin Toxicol (Phila); 2018 Jun; 56(6):404-411. PubMed ID: 29072524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro Phase I Metabolic Profiling of the Synthetic Cannabinoids AM-694, 5F-NNEI, FUB-APINACA, MFUBINAC, and AMB-FUBINACA.
    Apirakkan O; Gavrilović I; Cowan DA; Abbate V
    Chem Res Toxicol; 2020 Jul; 33(7):1653-1664. PubMed ID: 32301604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioseparation of the carboxamide-type synthetic cannabinoids N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide and methyl [1-(5-fluoropentyl)-1H-indazole-3-carbonyl]-valinate in illicit herbal products.
    Doi T; Asada A; Takeda A; Tagami T; Katagi M; Kamata H; Sawabe Y
    J Chromatogr A; 2016 Nov; 1473():83-89. PubMed ID: 27773389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal intoxication by 5F-ADB and diphenidine: Detection, quantification, and investigation of their main metabolic pathways in humans by LC/MS/MS and LC/Q-TOFMS.
    Kusano M; Zaitsu K; Taki K; Hisatsune K; Nakajima J; Moriyasu T; Asano T; Hayashi Y; Tsuchihashi H; Ishii A
    Drug Test Anal; 2018 Feb; 10(2):284-293. PubMed ID: 28544560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I metabolism of the carbazole-derived synthetic cannabinoids EG-018, EG-2201, and MDMB-CHMCZCA and detection in human urine samples.
    Mogler L; Franz F; Wilde M; Huppertz LM; Halter S; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2018 Sep; 10(9):1417-1429. PubMed ID: 29726116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of APINACA, 5F-APINACA, UR-144 and its degradant product in blood samples from six impaired drivers compared to previous reported concentrations of other synthetic cannabinoids.
    Karinen R; Tuv SS; Øiestad EL; Vindenes V
    Forensic Sci Int; 2015 Jan; 246():98-103. PubMed ID: 25485949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoassay screening in urine for synthetic cannabinoids - an evaluation of the diagnostic efficiency.
    Franz F; Angerer V; Jechle H; Pegoro M; Ertl H; Weinfurtner G; Janele D; Schlögl C; Friedl M; Gerl S; Mielke R; Zehnle R; Wagner M; Moosmann B; Auwärter V
    Clin Chem Lab Med; 2017 Aug; 55(9):1375-1384. PubMed ID: 28130957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
    Ford LT; Berg JD
    Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Death after use of the synthetic cannabinoid 5F-AMB.
    Shanks KG; Behonick GS
    Forensic Sci Int; 2016 May; 262():e21-4. PubMed ID: 27017174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of metabolites of the synthetic cannabinoid JWH-018 in urine after controlled inhalation.
    Toennes SW; Geraths A; Pogoda W; Paulke A; Wunder C; Theunissen EL; Ramaekers JG
    J Pharm Biomed Anal; 2018 Feb; 150():162-168. PubMed ID: 29245085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
    Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
    Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of AB-FUBINACA metabolites in authentic urine samples suitable as urinary markers of drug intake using liquid chromatography quadrupole tandem time of flight mass spectrometry.
    Vikingsson S; Gréen H; Brinkhagen L; Mukhtar S; Josefsson M
    Drug Test Anal; 2016 Sep; 8(9):950-6. PubMed ID: 26560240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comprehensive investigation on synthetic cannabinoids: Metabolic behavior and potency testing, using 5F-APP-PICA and AMB-FUBINACA as model compounds.
    Fabregat-Safont D; Mardal M; Noble C; Cannaert A; Stove CP; Sancho JV; Linnet K; Hernández F; Ibáñez M
    Drug Test Anal; 2019 Sep; 11(9):1358-1368. PubMed ID: 31192526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A liquid chromatography-mass spectrometry method based on class characteristic fragmentation pathways to detect the class of indole-derivative synthetic cannabinoids in biological samples.
    Mazzarino M; de la Torre X; Botrè F
    Anal Chim Acta; 2014 Jul; 837():70-82. PubMed ID: 25000860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.